Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cannabinoid induced behavioral convulsions in rabbits

P Martin, P Consroe

    Science (New York, N.Y.)
    |November 26, 1976
    PubMed
    Summary

    Researchers identified a specific group of rabbits that experience physical seizures when exposed to marijuana-derived compounds. These animals show reduced reactions over time with repeated exposure. This unique sensitivity makes them a potential tool for studying how these substances affect the brain.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Brain cannabinoid systems as targets for the therapy of neurological disorders.

    Neurobiology of disease·1999
    Same author

    AM630 is an inverse agonist at the human cannabinoid CB1 receptor.

    Life sciences·1998
    Same author

    Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain.

    European journal of pharmacology·1998
    Same author

    SR141716A is an inverse agonist at the human cannabinoid CB1 receptor.

    European journal of pharmacology·1997
    Same author

    delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain.

    European journal of pharmacology·1997
    Same author

    AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain.

    European journal of pharmacology·1997

    Area of Science:

    • Pharmacology and toxicology research involving cannabinoid induced behavioral convulsions
    • Animal model development in neuroscience

    Background:

    Scientific understanding regarding the specific physiological reactions to marijuana compounds remains incomplete in certain animal models. No prior work had resolved why particular populations display intense physical responses to these substances. Researchers previously established that various species react differently to psychoactive agents. That uncertainty drove the investigation into unique behavioral patterns within specific rabbit groups. This gap motivated a closer look at how these animals process chemical stimulants. It was already known that cannabinoids exert complex effects on the central nervous system. Prior research has shown that tolerance often develops following prolonged exposure to these compounds. This study addresses the lack of documented models for studying stimulant-related seizure activity in lagomorphs.

    Purpose Of The Study:

    The aim of this investigation is to characterize the behavioral responses of a specific rabbit population to psychoactive marijuana compounds. This study addresses the need for reliable animal models to examine the stimulant properties of these substances. Researchers sought to determine if these animals exhibit consistent physical reactions to intravenous administration. The motivation stems from the observation of unexpected convulsive activity in this group. By documenting these events, the team intended to establish a baseline for further pharmacological analysis. This work explores whether these reactions persist or diminish with repeated substance exposure. The authors aimed to clarify the utility of these rabbits in broader neurobiological research. Understanding these responses helps define the scope of the model for future scientific inquiry.

    Keywords:
    New Zealand White rabbitsdelta9-tetrahydrocannabinolpharmacological modelstimulant action

    Frequently Asked Questions

    According to the authors, these animals exhibit physical seizures upon receiving low intravenous doses of marijuana-derived psychoactive compounds. This response is distinct from typical reactions observed in other populations. The intensity of these events diminishes following chronic exposure to delta9-tetrahydrocannabinol.

    The researchers utilized New Zealand White rabbits for their investigation. This breed was selected due to their unique sensitivity to the stimulant effects of the administered substances. Other species do not display this specific convulsive phenotype under identical experimental conditions.

    The authors note that intravenous administration is necessary to elicit the observed behavioral response. This delivery route ensures that the compounds reach the central nervous system rapidly. Oral or topical applications might not produce the same immediate physical manifestations.

    Related Experiment Videos

    Main Methods:

    Review Approach involved evaluating the behavioral responses of New Zealand White rabbits to specific chemical agents. The investigators administered low intravenous doses of psychoactive marijuana compounds to the subjects. They monitored the animals for the emergence of involuntary physical movements. The team recorded the severity of these events during initial and subsequent exposures. They implemented a long-term dosing schedule to assess changes in reaction patterns. This systematic observation allowed for the tracking of symptom progression over time. The researchers compared initial responses against those occurring after prolonged substance administration. This methodology focused on documenting the development of tolerance to the stimulant effects.

    Main Results:

    Key Findings From the Literature demonstrate that this specific rabbit population displays involuntary physical movements when exposed to low intravenous doses of psychoactive marijuana compounds. The intensity of these events shows a marked decrease following the long-term administration of delta9-tetrahydrocannabinol. Eventually, these physical responses disappear entirely after repeated exposure. The subjects exhibit extreme sensitivity to the stimulant properties of these substances. This unique reactivity distinguishes them from other populations commonly used in pharmacological testing. The data indicate that the severity of the reaction is dose-dependent and time-sensitive. These findings establish a clear pattern of behavioral change in response to chronic treatment. The results highlight the potential for using these animals to study stimulant-related mechanisms.

    Conclusions:

    Synthesis and Implications indicate that this specific rabbit population provides a viable platform for future investigations. The authors propose that these animals serve as a model for stimulant-related research. Observations suggest that repeated exposure leads to a decline in seizure intensity. This phenomenon mirrors tolerance patterns seen in other biological systems. The researchers highlight that these subjects exhibit extreme sensitivity to the compounds tested. Such findings offer a pathway to better understand the mechanisms behind these physical reactions. The evidence supports the utility of this model for examining stimulant actions. Future work might utilize these findings to explore the underlying neurobiology of these responses.

    The study relies on behavioral observation data to track the severity of the convulsions. This qualitative approach allows researchers to document the onset and eventual disappearance of symptoms. Quantitative measurements of dosage are also recorded to establish the sensitivity threshold.

    The researchers measured the frequency and intensity of the convulsions over time. They observed that these physical events decrease in severity after long-term administration of delta9-tetrahydrocannabinol. This measurement confirms the development of tolerance within the test group.

    The authors propose that this population serves as a model for studying the stimulant action of cannabinoids. They suggest that this sensitivity allows for a deeper exploration of how these substances trigger physical responses. This model provides a controlled environment for future pharmacological assessments.